ADACEL is indicated for active booster immunization for the prevention of tetanus, diphtheria
and pertussis (whooping cough) in person 4 to 6 years of age and 10 years or older.
ADACEL is indicated for passive protection against pertussis in early infancy following maternal immunization during pregnancy (see DOSAGE & ADMINISTRATION and PRECAUTIONS).
ADACEL should be used in accordance with official recommendations.
In accordance with local recommendations, Adacel may be considered as an alternative for the fifth dose of tetanus, diphtheria and acellular pertussis vaccine (DTaP) (TDap) in children 4 to 6 years of age, concomitantly administered with inactivated Poliomyelitis Vaccine (IPV) at separate sites to complete the vaccination series of this age when indicated.
ADACEL is not to be used for the treatment of disease caused by Bordetella pertussis, Corynebacterium diphtheriae or Clostridium tetani infections.
Pediatrics: ADACEL is not indicated for immunization of children below the age of 4 years.
Tetanus Prophylaxis in Wound Management: The need for active immunization with a tetanus toxoid-containing preparation such as Td adsorbed vaccine or Adacel, with or without passive immunization with tetanus Immune Globulin, depends on both the condition on the wound and the patients vaccination history.
Other Services
Country
Account